"We Envision Growth Strategies Most Suited
to Your Business"
In the 1970s, the Maxam-Gilbert sequencing method transformed biology from laborious base-to-base reads to effective and systematic decoding of genomes. This laid the foundation for sequencing-by-synthesis and other next-generation chemistries development by different research centers and prominent firms.
Currently, sequencing consumables span library-preparation kits, flow cells, reagents, and cartridges, showcasing longer reads and single-molecule approaches. These are automated and categorized workflows with assay tailored for clinical programs. Companies are introducing room-temperature stable reagents, chemistry optimized platforms, and rapid benchtop systems to advance the shortened turnaround and reduce hands-on time. Together, technology development, accelerated reagents and automation design frames the current sequencing consumables industry.
Fortune Business Insights reported that the sequencing consumables industry is observing a substantial growth with a CAGR of 16.95% and is expected to reach a revenue of USD 13.96 billion in 2026 and increase to USD 48.86 billion by 2034.
Thermo Fisher Scientific Inc., is known for its comprehensive portfolio of consumables that are designed especially for Ion Torrent (next generation sequencing) and Applied Biosystems (sanger sequencing) platforms. These consumables operate across the complete workflow for sample preparation to analysis and sequencing, thus catering to applications in forensics, clinical research, and academic research. In March 2022, the company launched CE-IVD-marked Ion Torrent Genexus Dx Integrated Sequencer which is a next-generation sequencing and automated platform providing results in short duration.
Illumina, Inc., is a prominent firm headquartered in the U.S. It offers various sequencing consumables for market leading NGS platforms, representing the majority of the company’s revenue. The product line including flow cells, reagents, and library preparation kits is based on Sequencing by Synthesis (SBS) technology with higher accuracy. In January 2025, the company updated its NovaSeq X Series that delivers the NovaSeq X Single-Flow-Cell system with modern software upgrades. In October 2024, the company launched MiSeq i100 Series of sequencing systems to improve NGS for laboratories.
Agilent Technologies, Inc. expertise in upstream and downstream aspects of NGS workflows as compared to sequencing instruments. These offerings are designed to improve the reproducibility, accuracy and efficiency of target enrichment, library preparation, and quality control. The company is an industry leader with the SureSelect portfolio, allowing researchers to focus on specific genomic regions.
QIAGEN, a well-known company, offers sequencing consumables under its QIAseq brand, designed to cover the whole NGS workflow from sample extraction to library preparation and bioinformatics analysis. The company’s kits are designed for enzymatic fragmentation and library preparation. Its key features include automation, accuracy, sensitivity, compatibility, sustainability, and efficiency.
Danaher Corporation offers a suite of sequencing consumables basically through its Biotechnology and Life Sciences operating companies with a wide focus on library construction, sample preparation, and targeting enrichment for NGS. Some major contributors to this portfolio include Beckman Coulter Life Sciences, Aldevron, and Integrated DNA Technologies. The company strategically focuses on “sequence-to-vial” capabilities that aims at reducing errors in the development of genomic medicines.
Twist Bioscience Corporation is one of the top 10 sequencing consumable brands that leverages their proprietary silicon based DNA synthesis platform to produce synthetic oligonucleotide probes and reagents. This focuses on target enrichment and specialized kits for different clinical and research applications to improve sequencing efficiency and accuracy.
Oxford Nanopore Technologies plc., is a prominent firm that provides sequencing consumables centering their proprietary flow cells as well as library preparation kits. This enables real-time, direct and long-read analysis of RNA and DNA. The company’s business model emphasizes on offering scalable hardware and charging for such consumables.
PacBio offers consumables for its Bega, Revio, Onso, and Sequel II/IIe sequencing system that specializes in High Molecular Weight (HMW) DNA extraction, specialized kits for RNA, SMRTbell library preparation, and microbial research. Some of its key offerings include SMRT Cells, Nanobind magnetic disks, Kinnex Kits, and polymerase kits. In August 2023, the company collaborated with University of Washington to research the capabilities of HiFi long-read Whole Genome Sequencing (WGS). This increases diagnostic rates in pediatric patients with genetic conditions.
10x Genomics, Inc., is a significant sequencing consumables provider that is designed to work with its hardware platforms including Visium, Chromium, and Xenium. These aid in enabling single cell, spatial, and in situ biological analysis. The company in January 2026, collaborated with Brigham & Women's Hospital to analyze peripheral blood samples from patients living with Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Giant Cell Arteritis (GCA). This also uncovers the immune signatures associated with disease flare, activity, remission, and therapeutic responses.
F.Hoffmann-La Roche Ltd., offers an exclusive portfolio of NGS consumables that are designed to streamline workflows from sample preparation to target enrichment. The company’s offerings are primarily branded under the KAPA and AVENIO lines that are designed for higher performance RNA and DNA library preparation and quantification. This offers workflow automation, engineered enzymes, and higher flexibility.
Looking ahead, sequencing consumables are predicted to become smarter and highly adaptive to integrated components as compared to standalone inputs. The future of this industry points toward self-calibrating chemistries, consumables designed for fully autonomous laboratories, and AI-based reagent optimization. With genomics moving closer to real-time decision-making across agriculture, healthcare and environmental science, consumables are expected to evolve and support faster cycling, seamless interoperability, and higher sensitivity. Additionally, sustainability is another factor, expected to shape the future designs with recyclable materials and less waste formats evolving as a standard. Innovations would merge hardware, software and chemistry, thus enabling effective workflow with higher space for improvements. Companies would compete by pairing scientific rigor with agile innovations by anticipating the emerging applications rather than reacting. Thus, the future suggests fundamental reimagining of how sequencing workflows are enabled.
+1 833 909 2966 ( Toll Free ) (US)
sales@fortunebusinessinsights.com